Published in Scand J Gastroenterol on July 01, 2001
Gastrin, somatostatin, G and D cells of gastric ulcer in rats. World J Gastroenterol (2002) 0.87
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy. Hum Vaccin Immunother (2014) 0.84
Vaccine therapy for pancreatic cancer. Oncoimmunology (2013) 0.84
Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas. BMC Res Notes (2011) 0.76
Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats. World J Gastroenterol (2005) 0.76
Pancreatic cancer: Update on immunotherapies and algenpantucel-L. Hum Vaccin Immunother (2016) 0.75
Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas (2014) 0.75
Assessment of historical land-use changes for purposes of strategic planning--a case study in Laos. Ambio (2001) 2.11
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med (2007) 1.06
Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology (1990) 1.05
Gastrectomy causes bone loss in the rat: is lack of gastric acid responsible? Scand J Gastroenterol (1993) 1.04
Liver resection of noncolorectal secondaries. J Surg Oncol (1998) 1.00
Gastrin releases a blood calcium-lowering peptide from the acid-producing part of the rat stomach. Proc Natl Acad Sci U S A (1989) 0.97
A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology (2011) 0.96
Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach. Gut (1990) 0.93
Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta (1996) 0.93
Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines. Scand J Gastroenterol (2004) 0.93
An association between Type 2 diabetes and alpha-antitrypsin deficiency. Diabet Med (2008) 0.92
Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol (2001) 0.88
Elevated serum gastrin after food intake or acid blockade evokes hypocalcemia. Regul Pept (1990) 0.87
Vasopressin receptor mRNA expression in the human gastrointestinal tract. Eur Surg Res (2007) 0.87
Quantification of platelet-bound IgG by 125I-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders. Blood (1984) 0.87
Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells. Ann N Y Acad Sci (2000) 0.87
Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone. Regul Pept (1990) 0.86
Functional bowel symptoms and GnRH antibodies: common findings in patients with primary Sjögren's syndrome but not in systemic sclerosis. Scand J Rheumatol (2009) 0.86
Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach. Scand J Gastroenterol (1992) 0.86
Cholecystokinins but not gastrin-17 release calcitonin from thyroid C-cells in the rat. Regul Pept (1988) 0.86
Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats. Scand J Gastroenterol (1993) 0.84
Pancreatic biopsy: why? When? How? World J Surg (1999) 0.83
Cholecystokinin increases small intestinal motility and reduces enteric bacterial overgrowth and translocation in rats with surgically induced acute liver failure. Digestion (1996) 0.83
Preoperative ropivacaine infiltration in breast surgery. Acta Anaesthesiol Scand (2000) 0.83
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med (2011) 0.83
Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signaling and recognition. Cell Mol Life Sci (2003) 0.83
Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects. Neurogastroenterol Motil (2010) 0.82
Effects of some different pulse parameters on bladder inhibition and urethral closure during intravaginal electrical stimulation: an experimental study in the cat. Med Biol Eng Comput (1986) 0.82
The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Scand J Gastroenterol (1999) 0.82
Coexistent chronic idiopathic intestinal pseudo obstruction and inflammatory bowel disease. Gut (2005) 0.81
Nutritional aspects in patients with functional gastrointestinal disorders and motor dysfunction in the gut. Working team report of the Swedish Motility Group (SMoG). Dig Liver Dis (2007) 0.81
Epidermal growth factor induces cell proliferation in mouse pancreas and salivary glands. Pancreas (1997) 0.81
Hypergastrinaemia evoked by omeprazole stimulates growth of gastric mucosa but not of pancreas or intestines in hamster, guinea pig and chicken. Regul Pept (1988) 0.81
The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation. Pancreas (1995) 0.80
Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor. Int J Pancreatol (1995) 0.80
Green banana protection of gastric mucosa against experimentally induced injuries in rats. A multicomponent mechanism? Scand J Gastroenterol (1993) 0.80
Celiac disease diagnosed using video capsule endoscopy in a patient with Crohn's disease. Endoscopy (2006) 0.80
The method of administration of cholecystokinin determines the effects evoked in the pancreas. Pancreas (2001) 0.79
Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas. Scand J Gastroenterol (1997) 0.79
Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats. Scand J Gastroenterol (1990) 0.79
Operations for extrahepatic bile duct cancers: are the results really improving? Eur J Surg (2000) 0.78
Inhibitory effects of N-acetylcysteine on scavenger receptor class A expression in human macrophages. J Intern Med (2002) 0.78
Antibodies against GnRH and its receptor in patients with primary Sjögren's syndrome. Scand J Rheumatol (2014) 0.78
Acute taurodeoxycholate-induced pancreatitis in the rat is associated with hyperCCKemia. Int J Pancreatol (2000) 0.78
Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas. Scand J Gastroenterol (2000) 0.78
[Combination therapy in oncology (multimodal treatment) in pancreatic tumors]. Chirurg (1998) 0.77
The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin. Int J Pancreatol (1996) 0.77
Pancreaticogastrostomy after subtotal pancreatectomy for cancer. Dig Surg (1999) 0.77
Immunohistochemical expression of metallothionein in resected hepatic primary tumors and colorectal carcinoma metastases. APMIS (1999) 0.77
Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas. Int J Pancreatol (2000) 0.77
Does vagotomy affect the growth of the pancreas in the rat? Scand J Gastroenterol (1992) 0.77
CCK stimulates growth of both the pancreas and the liver. Int J Surg Investig (1999) 0.76
Total parenteral nutrition influences both endocrine and exocrine function of rat pancreas. Pancreas (1997) 0.76
Cortical evoked potentials following stimulation of the urinary bladder in man. Electroencephalogr Clin Neurophysiol (1982) 0.76
Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion. Scand J Gastroenterol (1993) 0.76
Conservative treatment in acute pancreatitis. Ann Ital Chir (1995) 0.76
Devazepide-induced hyperplasia in the rat liver and bile ducts. Eur Surg Res (1996) 0.76
[Diaphanography for assessment of breast changes]. Lakartidningen (1979) 0.75
The inhibitory effect of an EGF receptor-specific tyrosine kinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF I. Int J Pancreatol (1998) 0.75
Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt. Pancreas (2000) 0.75
Trophic effects of gastrin and cholecystokinin. Z Gastroenterol Verh (1991) 0.75
Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects. Eur J Clin Pharmacol (1990) 0.75
Surgical treatment for patients with advanced pancreatic cancer. J Hepatobiliary Pancreat Surg (1998) 0.75
An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver. Eur Surg Res (1998) 0.75
Diaphanography: a method for evaluation of the female breast. World J Surg (1980) 0.75
[Report on Swedish Midwives' Association's activities from 1 January 1982 - 31 December 1982]. Jordemodern (1983) 0.75
The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas. Int J Pancreatol (1998) 0.75
Pancreatic pain: is there a medical alternative to surgery? Digestion (1993) 0.75
Stimulation with cholecystokinin leads to increased ratio between mRNA levels for anionic and cationic trypsinogen in rat pancreas. J Gastroenterol (1997) 0.75
The rat gastric phospholipids: increased in ulcerated mucosa and decreased after healing. Eur Surg Res (1993) 0.75
[Now I am ready to start planning]. Vardfacket (1978) 0.75
Cortical evoked potentials obtained after stimulation of the lower urinary tract. J Urol (1984) 0.75
Biliodigestive shunt evokes hyperCCKemia and trophic effects in the rat pancreas, but not in the liver or gastrointestinal tract. Pancreas (1997) 0.75
Intravenously administered human epidermal growth factor in the rat. Biliary excretion and influences on pancreatic secretion. Eur Surg Res (2003) 0.75
Development of porcine pancreatic hydrolases and their isoenzymes from the fetal period to adulthood. Pancreas (1987) 0.75
Convenience food use in households with male food preparers. J Am Diet Assoc (1986) 0.75